Poseida Therapeutics (PSTX) Q1 2023 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.76
-0.2
0.36
0.92

Details

Expected EPS
-0.45
Actual EPS
-0.45
Surprise EPS
0
Surprise Percent
+0%

Description

Poseida Therapeutics (PSTX) has reported earnings of -0.45 per share for Q1 2023.

0 Comments

Share your thoughts